Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX) - a randomized phase II trial of the AIO pancreatic cancer group

ISSN
0923-7534
Date Issued
2022
Author(s)
Seufferlein, T.
Uhl, W.
Kornmann, M.
Algül, H.
Friess, H.
Gallmeier, E.
Bartsch, D.K.
Lutz, M.P.
Ettrich, T.J.
DOI
10.1016/j.annonc.2022.09.161